Literature DB >> 18827745

Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organism.

Reetta Huttunen1, Mikko Hurme, Janne Laine, Carita Eklund, Risto Vuento, Janne Aittoniemi, Heini Huhtala, Jaana Syrjänen.   

Abstract

Nitric oxide (NO) as a vasoactive substance is a crucial element in the pathogenesis of sepsis. Endothelial NO synthase (eNOS) is, in turn, a key regulator of vascular NO production. The eNOS gene polymorphism at position 894 (G>T, Glu298Asp) resulting in T allele has been studied in the context of vascular diseases, but its role in sepsis has not yet been explored. We here studied the effect of eNOS Glu298Asp polymorphism on the clinical course of the disease in patients with bacteremia. The study comprised 147 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, beta-hemolytic streptococci, or Escherichia coli. Laboratory findings and clinical data were registered on admission and during 6 consecutive days. The polymorphism of eNOS gene, G894T, was genotyped. Carriage of the T allele was associated with low MAP (P = 0.004) and high Sequential Organ Failure Assessment score (P = 0.001) in patients with E. coli bacteremia. The effect on blood pressure was most prominent in the early stage of the disease (MAP on admission = 52 mmHg in T-allele carriers vs. 91 mmHg in noncarriers; P < 0.001). However, the same was not detected in bacteremia caused by a gram-positive organism (S. aureus, S. pneumoniae, or beta-hemolytic streptococci). The Glu298Asp polymorphism had no effect on case fatality in any pathogen. Carriage of the T allele of the eNOS gene is a risk factor for hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18827745     DOI: 10.1097/SHK.0b013e318188e58e

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

Review 1.  Association between endothelial nitric oxide synthase polymorphisms and atrial fibrillation: a meta-analysis.

Authors:  Hongying Chen; Hongxia Chu; Yu Shi; Soumitra Sudip Bhuyan; Jian ping Li; Shao Rong Liu; Jun Yang
Journal:  J Cardiovasc Transl Res       Date:  2012-06-22       Impact factor: 4.132

2.  Inhibition of neuronal nitric oxide synthase activity does not alter vasopressin secretion in septic rats.

Authors:  Camila Henriques Coelho; Thalita Freitas Martins; Gabriela Ravanelli Oliveira-Pelegrin; Maria José Alves da Rocha
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

3.  Nos3 protects against systemic inflammation and myocardial dysfunction in murine polymicrobial sepsis.

Authors:  Masahiko Bougaki; Robert J Searles; Kotaro Kida; JiaDe Yu; Emmanuel S Buys; Fumito Ichinose
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

Review 4.  Bench-to-bedside review: nitric oxide in critical illness--update 2008.

Authors:  Steven M Hollenberg; Ismail Cinel
Journal:  Crit Care       Date:  2009-07-16       Impact factor: 9.097

5.  Right man, right time, right place?--on the time course of the mediator orchestra in septic shock.

Authors:  Balázs Hauser; Peter Radermacher
Journal:  Crit Care       Date:  2010-08-23       Impact factor: 9.097

Review 6.  Bench-to-bedside review: sepsis - from the redox point of view.

Authors:  Michael Éverton Andrades; Arian Morina; Snežana Spasić; Ivan Spasojević
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

7.  Risk Factors for Normal and High-Tension Glaucoma in Poland in Connection with Polymorphisms of the Endothelial Nitric Oxide Synthase Gene.

Authors:  Ewa Kosior-Jarecka; Urszula Łukasik; Dominika Wróbel-Dudzińska; Janusz Kocki; Joanna Bartosińska; Agnieszka Witczak; Grażyna Chodorowska; Jerzy Mosiewicz; Tomasz Żarnowski
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.